Patents

Two U.S. patents allowed regarding delivery systems

Published in Health and Medicine Week, October 10th, 2005

Bioheart, Inc., announced that the U.S. Patent and Trademark Office issued a notice of allowance regarding two of its patent applications: 10/152,110, entitled "Deflectable Microimplant Delivery System" and 10/181,741, entitled "Apparatus for Inserting Particles Into Tissue."

The patent applications, acquired by Guidant Corp. in June 2003 and licensed back to Bioheart on a co- exclusive basis, cover delivery systems for delivering cells, therapeutic agents, particles, and/or other biologics to human tissues.

Bioheart is focused on repairing damaged heart muscle with its MyoCell product, a myogenic cell composition made up of adult muscle stem cells...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week

Source: Health and Medicine Week (2005-10-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry